Skip to main content

Advertisement

Log in

Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objective

The aim of this study was to determine the efficacy and safety of viscosupplementation applied to the hip joint with the lateral approach and ultrasound guidance and to show whether this can be an alternative treatment model in hip osteoarthritis (OA).

Methods

We performed three hylan G-F injections each to 14 patients with hip OA. We evaluated visual analog score (VAS), Lequesne hip OA severity index, 15-meter walking time before injections and 30 and 90 days after injections, and patient satisfaction.

Results

We established that after 30 respectively 90 days of treatment, VAS, Lequesne hip OA severity index, and 15-meter walking time were statistically significantly lower than before the treatment. This decrease continued after the 30th day. No side effects or complications were observed.

Conclusions

Viscosupplementation performed under ultrasound guidance with the lateral approach is an effective and safe method and can be an alternative treatment of hip OA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Migliore A, Martin LSM, Alimonti A, Valente C, Tormenta S (2003) Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 11:305–306

    Article  CAS  PubMed  Google Scholar 

  2. Balazs EA, Denlinger JL (1993) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 20 [Suppl 39]:3–9

  3. Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L (2002) Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 69:388–391

    Article  PubMed  Google Scholar 

  4. Leopold SS, Battista V, Oliverio JA (2001) Safety and efficacy of intraarticular hip injection using anatomic landmarks. Clin Orthop 391:192–197

    PubMed  Google Scholar 

  5. Qvistgaard E, Kristoffersen H, Terslev L, Danneskiold-Samsoe B, Torp-Petersen S, Bliddal H (2001) Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 9:512–517

    Article  CAS  PubMed  Google Scholar 

  6. Altman R, Alarcon G, Appelrouth D (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505–514

    CAS  PubMed  Google Scholar 

  7. Kellgren JH, Lawrence JS (1957) Radiologic assessment of osteoarthrosis. Ann Rheum Dis 16:494–501

    CAS  Google Scholar 

  8. Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for OA of the hip and knee. Scand J Rheumatol [Suppl 65]:85–89

  9. Saunder S, Cameron G (1997) Injection techniques in orthopaedic and sports medicine. Saunders, London

  10. Simon LS (1999) Viscosupplementation therapy with intraarticular hyaluronic acid. Rheum Dis Clin North Am 25:345–357

    CAS  PubMed  Google Scholar 

  11. Conrozier T, Mathieu P, Schott AM, Laurent I, Hajri T, Crozes P, Grand P, Laurent H, Marchand F, Meignan F, Noel E, Rozand Y, Savoye JF, Vignon E (2003) Factors predicting long-term efficacy of Hylan G-F 20 viscosupplementation in knee OA. Joint Bone Spine 70:128–133

    Article  PubMed  Google Scholar 

  12. Wobig M, Dickhut A, Maier R, Vetter G (1998) VS with hylan G-F 20: a 26 week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20:410–423

    Article  CAS  PubMed  Google Scholar 

  13. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R (1996) VS with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 23:1579–1585

    CAS  PubMed  Google Scholar 

  14. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, Zummer M (1995) The role of viscosupplementation with hylan G-F 20 (synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with nonsteroidal antiinflammatory drugs (NSAIDs) and NSAIDs alone. Ost Cartilage 3:213–225

    Google Scholar 

  15. Chevalier X, Conrozier T, Bertin P, Bailleul F, Vignon E (2000) Treatment of patients with symptomatic hip OA—a pilot study with intra-articular Hylan G-F 20 (Synvisc). Arthritis Rheum 43:384

    Google Scholar 

  16. Lanzotti SB, Machado MB, Nascimento RA, Souza SAA, Aaujo JC Jr, Torres VNM (2000) Intra-articular sodium hyaluronate in unilateral coxofemoral osteoarthritis treatment. Arthritis Rheum 43:336

    Article  PubMed  Google Scholar 

  17. Carson BW, Wong A (1999) Ultrasonographic guidance for injections of local steroids in the native hip. J Ultrasound Med 18:159–160

    CAS  PubMed  Google Scholar 

  18. Scale D, Wobig M, Wolpert W (1994) Viscosupplementation of osteoarthritis knees with hylan: a treatment schedule study. Current Ther Res 56:220–232

    Google Scholar 

  19. Chen AL, Desai P, Adler EM, Di Cesare PE (2002) Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases. J Bone Joint Surg Am 84:1142–1147

    Article  Google Scholar 

  20. Zardawi IM, Chan I (2001) Synvisc perisynovitis. Pathology 33:519–520

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hanife Caglar-Yagci.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caglar-Yagci, H., Unsal, S., Yagci, I. et al. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 25, 341–344 (2005). https://doi.org/10.1007/s00296-004-0441-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-004-0441-5

Keywords

Navigation